MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Options

Stock Options

3 Months Ended

Mar. 31, 2020

NOTE 13 – STOCK OPTIONS

During the three months ended March 31, 2019, options to purchase 150,000 shares of common stock were exercised at prices of $0.26 and $0.77 per share. Of these exercised options, 100,000 were exercised on a cashless basis with the exercise prices paid via the surrender of 19,376 shares of common stock. No options were exercised during the three months ended March 31, 2020.

During the three months ended March 31, 2020, options to purchase 30,000 shares of common stock were forfeited, resulting in an aggregate reduction of amortization expense of approximately $19,000. No options were forfeited during the three months ended March 31, 2019.

Stock options outstanding and exercisable as of March 31, 2020 were:

Exercise Price		Shares Under Option				Remaining
per Share		Outstanding		Exercisable		Life in Years
$	0.130		200,000		200,000		0.25
$	0.140		550,000		550,000		0.75
$	0.330		50,000		50,000		0.94
$	0.417		900,000		200,000		4.74
$	0.450		125,000		125,000		1.51
$	0.590		15,000		-		4.69
$	0.630		300,000		300,000		1.75
$	0.770		200,000		200,000		2.75
$	0.900		50,000		50,000		3.12
$	0.910		50,000		50,000		2.56
$	0.950		50,000		30,000		2.75
$	0.992		300,000		300,000		4.49
$	1.000		170,000		120,000		4.59
$	1.350		100,000		25,000		3.33
$	1.950		500,000		125,000		3.25
$	2.320		100,000		100,000		3.45
$	2.450		2,000,000		2,000,000		2.73
$	2.500		100,000		75,000		3.41
$	2.650		200,000		150,000		3.48
$	2.850		56,250		31,250		2.70
$	2.850		100,000		50,000		3.70
$	3.000		25,000		25,000		3.71
$	3.725		100,000		100,000		3.69
			6,241,250		4,856,250